Vascular endothelial growth factor family members are differentially regulated by c-erbB signaling in head and neck squamous carcinoma cells

Clinical and Experimental Metastasis

Volumn 18, Issue 2, 2000, Pages 155-161

  O charoenrat, Pornchai ^a   Rhys Evans, Peter ^a   Modjtahedi, Helmout ^b   Eccles, Suzanne ^c  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Angiogenesis; c erbB receptors and ligands; Epidermal growth factor receptor; Head and neck cancer; Lymphangiogenesis; Vascular endothelial growth factor

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ARTICLE; BINDING AFFINITY; DOWN REGULATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; ONCOGENE C ERB; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

ANTIBODIES, MONOCLONAL; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA PRIMERS; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; HEAD AND NECK NEOPLASMS; HUMANS; LIGANDS; LYMPHOKINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035116241     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006764100867     Document Type: Article

References (28)

1. Patterns emerging mechanisms of the angiogenic switch during tumorigenesis
2. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
3. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor
4. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
5. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
6. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family
7. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases
8. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
9. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer
10. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer
11. Expression of vascular endothelial growth factors A, B, C and D and their relationships to lymph node status in lung adenocarcinoma
12. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck
13. Biochemical and clinical implications of the ErbB/HER signalling network of growth factor receptors
14. Cell biology of lymphatic metastasis. The potential role of c-erbB oncogene signalling
15. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck
16. Epidermal growth factor-like ligands differentially upregulate matrix metalloproteinase-9 in head in head and neck squamous carcinoma cells
17. Over-expression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion
18. Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands
19. Expression and regulation of c-erbB ligands in human head and neck squamous carcinoma cells
20. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: Angiogenic implications for signal transduction therapy of solid tumors
21. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice
22. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia
23. Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation
24. Concentration of dilute protein for gel electrophoresis
25. Mutant ras oncogene up-regulates VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis
26. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
27. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, high affinity binding to Flk-1/KDR
28. Epidermal growth factor receptor expression in primary laryngeal cancer: An independent prognostic factor of neck node relapse